Covered recipient · General Payments record
SIMHADRI M GUPTA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,694.55
- Reported across 154 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $658.00 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $207.98 | 7 |
| EISAI INC. | $143.68 | 5 |
| Abbott Laboratories | $139.55 | 1 |
| Amgen Inc. | $106.18 | 1 |
| Biogen, Inc. | $44.38 | 2 |
| PFIZER INC. | $16.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $139.55 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125252062 | CMS |
| Amgen Inc. | $106.18 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115688193 | CMS |
| Biogen, Inc. | $29.96 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104829050 | CMS |
| Biogen, Inc. | $14.42 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104860152 | CMS |
| Eisai Inc. | $15.77 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110781684 | CMS |
| Eisai Inc. | $105.76 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110781678 | CMS |
| Eisai Inc. | $9.51 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110781680 | CMS |
| Eisai Inc. | $11.17 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110781682 | CMS |
| Eisai Inc. | $1.47 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110781686 | CMS |
| Lilly USA, LLC | $18.87 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135407304 | CMS |
| Lilly USA, LLC | $20.25 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135420583 | CMS |
| Lilly USA, LLC | $20.47 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135427230 | CMS |
| Lilly USA, LLC | $17.55 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135411725 | CMS |
| Lilly USA, LLC | $4.96 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135379870 | CMS |
| Lilly USA, LLC | $22.05 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135407306 | CMS |
| Lilly USA, LLC | $103.83 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135394341 | CMS |
| PFIZER INC. | $16.23 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131672855 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.